anmelden
Novartis Aktie
128,06
EUR
-0,08
EUR
-0,06
%
118,52
CHF
-0,26
CHF
-0,22
%
Novartis jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novartis Aktie Analyse
| 02.07.18 | Novartis Hold | Deutsche Bank AG | |
| 02.07.18 | Novartis Neutral | UBS AG | |
| 29.06.18 | Novartis buy | S&P Capital IQ | |
| 29.06.18 | Novartis buy | Baader Bank | |
| 29.06.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 29.06.18 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.06.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 27.06.18 | Novartis Hold | Deutsche Bank AG | |
|
Werbung
|
|||
| 25.06.18 | Novartis Underweight | Barclays Capital | |
| 18.06.18 | Novartis Underweight | Barclays Capital | |
| 04.06.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 31.05.18 | Novartis Hold | HSBC | |
| 29.05.18 | Novartis Hold | HSBC | |
| 25.05.18 | Novartis Neutral | Credit Suisse Group | |
| 22.05.18 | Novartis Underweight | Barclays Capital | |
| 17.05.18 | Novartis Hold | Deutsche Bank AG | |
| 17.05.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 14.05.18 | Novartis buy | Jefferies & Company Inc. | |
| 07.05.18 | Novartis buy | Kepler Cheuvreux | |
| 27.04.18 | Novartis Neutral | UBS AG | |
| 20.04.18 | Novartis buy | S&P Capital IQ | |
| 20.04.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 20.04.18 | Novartis Underperform | Credit Suisse Group | |
| 20.04.18 | Novartis Hold | Deutsche Bank AG | |
| 20.04.18 | Novartis Underweight | Barclays Capital | |
| 19.04.18 | Novartis Neutral | UBS AG | |
| 19.04.18 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.04.18 | Novartis Outperform | Bernstein Research | |
| 17.04.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 16.04.18 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.04.18 | Novartis buy | Jefferies & Company Inc. | |
| 12.04.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 12.04.18 | Novartis Hold | Deutsche Bank AG | |
| 11.04.18 | Novartis buy | HSBC | |
| 11.04.18 | Novartis Underweight | Barclays Capital | |
| 10.04.18 | Novartis Underperform | Credit Suisse Group | |
| 10.04.18 | Novartis Hold | Deutsche Bank AG | |
| 09.04.18 | Novartis buy | S&P Capital IQ | |
| 09.04.18 | Novartis Outperform | Bernstein Research | |
| 09.04.18 | Novartis Halten | Independent Research GmbH | |
| 09.04.18 | Novartis Neutral | UBS AG | |
| 09.04.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 09.04.18 | Novartis buy | Baader Bank | |
| 28.03.18 | Novartis buy | Oddo Seydler Bank AG | |
| 28.03.18 | Novartis Hold | Deutsche Bank AG | |
| 27.03.18 | Novartis buy | S&P Capital IQ | |
| 27.03.18 | Novartis buy | Baader Bank | |
| 27.03.18 | Novartis Neutral | UBS AG | |
| 14.03.18 | Novartis buy | Société Générale Group S.A. (SG) | |
| 02.03.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
Werbung
Werbung